STUDIES OF ISCHEMIA-REPERFUSION INJURY IN SKELETAL-MUSCLE - EFFICACY OF 21-AMINOSTEROIDS ON MICROCIRCULATION AND MUSCLE-CONTRACTION AFTER AN EXTENDED PERIOD OF WARM ISCHEMIA
Av. Korompilias et al., STUDIES OF ISCHEMIA-REPERFUSION INJURY IN SKELETAL-MUSCLE - EFFICACY OF 21-AMINOSTEROIDS ON MICROCIRCULATION AND MUSCLE-CONTRACTION AFTER AN EXTENDED PERIOD OF WARM ISCHEMIA, Journal of orthopaedic research, 15(4), 1997, pp. 512-518
The present study was conducted to elucidate the effects of tirilazad
mesylate (U-74006F), a potent inhibitor of lipid peroxidation, on vess
el diameter, capillary perfusion, and contractile function of rat crem
aster muscle during a 90-minute reperfusion period that followed 4 hou
rs of warm ischemia. Two groups of 32 animals were treated with either
3 mg/kg U-74006F or the vehicle (citrate buffer) alone 30 minutes bef
ore ischemia, 90 minutes after ischemia, and immediately before reperf
usion. With use of intravital videomicroscopy, the internal luminal di
ameters of preselected vessels were measured prior to ischemia and dur
ing reperfusion. The area that filled with fluorescein was determined
at 15-minute intervals for as long as 90 minutes of reperfusion, and c
ontractile function was examined in vitro in an organ bath Lit that po
int In the U-74006F group, after 90 minutes of reperfusion the vessel
diameters returned completely to baseline and the diameters of all thr
ee categories of vessels at every time point from 10 to 90 minutes of
reperfusion had significantly more rapid recovery than the controls. A
lthough some evidence of more rapid fluorescence was noted in the U-74
006F group, the: two groups did not differ significantly at any time p
eriod of reperfusion. In response to tetanic stimulation. the muscles
treated with U-74006F had a significantly greater contractile force at
all stimulation frequencies than the control muscles. Our findings in
dicate that pretreatment with U-74006F can effectively decrease the ri
se of vascular resistance and preserve the contractile function of ske
letal muscle during early reperfusion, thereby attenuating ischemia-re
perfusion injury.